CTOs on the Move

Black Diamond Therapeutics

www.blackdiamondtherapeutics.com

 
Black Diamond Therapeutics is a next-wave cancer precision medicine company. Black Diamond pioneered the development of selective medicines for patients with genetically defined cancers driven by oncogenes activated by allosteric mutations. Using its mutation, allostery, and pharmacology (MAP) computational and discovery platform, Black Diamond is uncovering new ways to functionally assess the mutational landscape of individual oncogenes – to discover and validate new targets and develop novel approaches to creating highly selective therapeutics. Black Diamond was founded by David M. Epstein, Ph.D., Elizabeth Buck, Ph.D., and Versant Ventures, and is the first new company to emerge from Versant`s Ridgeline Discovery ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Funding

Black Diamond Therapeutics raised $20M on 12/12/2018
Black Diamond Therapeutics raised $85M on 01/09/2019

Similar Companies

TotalAncillary

Comprehensive Solution for Revenue Generating Medical Ancillary Services

SPARC

We are a pharma research and drug discovery company.

Viking Therapeutics

Novel therapeutics for metabolic and endocrine disorders

Rx Systems

Rx Systems is a Saint Charles, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Robert E Mason Co

Robert E Mason Co is a Charlotte, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.